What is the global market size of Cell Banking Outsourcing Market?

Cell Banking Outsourcing Market size was valued at USD 9.90 billion in 2021 and is poised to grow from USD 10.60 billion in 2022 to USD 30.69 billion by 2030, growing at a CAGR of 16.40% in the forecast period (2023-2030).

Top Cell Banking Outsourcing Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Cell Banking Outsourcing Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Cell Banking Outsourcing industry players.

Cell Banking Outsourcing Market Competitive Landscape

Cell Banking Outsourcing Market Top Player’s Company Profiles

Lonza Group Ltd. (Switzerland)

SGS SA (Switzerland)

Charles River Laboratories International, Inc. (US)

WuXi AppTec (China)

Eurofins Scientific (Luxembourg)

Merck KGaA (Germany)

BioReliance Corporation (US)

Toxikon Corporation (US)

GlobalStem (US)

Paragon Bioservices, Inc. (US)

BSL Bioservice Scientific Laboratories GmbH (Germany)

ATCC (US)

BioOutsource Ltd. (UK)

ViruSure GmbH (Austria)

Sartorius AG (Germany)

Thermo Fisher Scientific Inc. (US)

Covance Inc. (US)

TATAA Biocenter AB (Sweden)

CellBank Australia (Australia)

StemExpress, LLC (US)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Banking Outsourcing Market size was valued at USD 15.59 Billion in 2024 and is poised to grow from USD 18.27 Billion in 2025 to USD 65.04 Billion by 2033, growing at a CAGR of 17.2% during the forecast period (2026–2033).

The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry. 'Charles River Laboratories (USA) ', 'Lonza (Switzerland) ', 'Merck KGaA (Germany) ', 'SGS Société Générale de Surveillance SA (Switzerland) ', 'Cryo-Cell International, Inc. (USA) ', 'LifeCell (India) ', 'WuXi AppTec (China) ', 'Eurofins Scientific (Luxembourg) ', 'Sartorius (Bio Outsource) (Germany) ', 'BSL Bioservice (Germany) ', 'ViaCord (USA) ', 'StemCyte, Inc. (USA) ', 'Cryoviva Biotech Pvt. Ltd. (India) '

One of the major drivers of the global cell banking outsourcing market is the increasing adoption of stem cell therapies. Stem cell therapy is a rapidly growing field of regenerative medicine that has the potential to treat a wide range of diseases and disorders. As the demand for stem cell therapies grows, the need for stable and high-quality cell lines increases, leading to a greater demand for cell banking services. This is driving the growth of the cell banking outsourcing market, as biopharmaceutical companies and CROs seek efficient and cost-effective solutions for producing and storing these valuable cell lines.

One key trend in the cell banking outsourcing market is the increasing demand for personalized medicine. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup. This requires the use of cells that are tailored to the specific needs of the patient. Cell banking outsourcing companies are investing in technologies that allow them to produce cells that are genetically matched to the patient. This trend is expected to drive the growth of the market as the demand for personalized medicine continues to increase.

North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.

Cell Banking Outsourcing Market

Report ID: SQMIG35D2076

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE

Top Cell Banking Outsourcing Companies

Cell Banking Outsourcing Market Competitive Landscape

FAQs

What is the global market size of Cell Banking Outsourcing Market?

Who are the key vendors in the Cell Banking Outsourcing Market?

What is the key driver of Cell Banking Outsourcing Market?

What is the key market trend for Cell Banking Outsourcing Market?

Which region accounted for the largest share in Cell Banking Outsourcing Market?

Request Free Customization